The novel treatment of this peptide represents a exciting breakthrough in the care of type 2 diabetes. Distinct from existing therapies, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatide-peptide258607.blogs-service.com/73153328/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment